Case Problem Professional

Sam 1 Sam 2 Sam 3 Sam 4

11.55 11.62 11.91 12.02

11.62 11.69 11.36 12.02

11.52 11.59 11.75 12.05

11.75 11.82 11.95 12.18

11.90 11.97 12.14 12.11

11.64 11.71 11.72 12.07

11.80 11.87 11.61 12.05

12.03 12.10 11.85 11.64

11.94 12.01 12.16 12.39

11.92 11.99 11.91 11.65

12.13 12.20 12.12 12.11

12.09 12.16 11.61 11.90

11.93 12.00 12.21 12.22

12.21 12.28 11.56 11.88

12.32 12.39 11.95 12.03

11.93 12.00 12.01 12.35

11.85 11.92 12.06 12.09

11.76 11.83 11.76 11.77

12.16 12.23 11.82 12.20

11.77 11.84 12.12 11.79

12.00 12.07 11.60 12.30

12.04 12.11 11.95 12.27

11.98 12.05 11.96 12.29

12.30 12.37 12.22 12.47

12.18 12.25 11.75 12.03

11.97 12.04 11.96 12.17

12.17 12.24 11.95 11.94

11.85 11.92 11.89 11.97

12.30 12.37 11.88 12.23

12.15 12.22 11.93 12.25

Non-diagnostic imaging

Neuroimaging has also been used in experimental circumstances to allow people (especially disabled persons) to control outside devices, acting as a brain computer interface.

Archiving and recording

Used primarily in ultrasound imaging, capturing the image produced by a medical imaging device is required for archiving and telemedicine applications. In most scenarios, a frame grabber is used in order to capture the video signal from the medical device and relay it to a computer for further processing and operations.

Use in pharmaceutical clinical trials

Medical imaging has become a major tool in clinical trials since it enables rapid diagnosis with visualization and quantitative assessment.

A typical clinical trial goes through multiple phases and can take up to eight years. Clinical endpoints or outcomes are used to determine whether the therapy is safe and effective. Once a patient reaches the endpoint, he/she is generally excluded from further experimental interaction. Trials that rely solely on clinical endpoints are very costly as they have long durations and tend to need large number of patients.

In contrast to clinical endpoints, surrogate endpoints have been shown to cut down the time required to confirm whether a drug has clinical benefits. Imaging biomarkers (a characteristic that is objectively measured by an imaging technique, which is used as an indicator of pharmacological response to a therapy) and surrogate endpoints have shown to facilitate the use of small group sizes, obtaining quick results with good statistical power.

Hope this explains you... :)

Non-diagnostic imaging

Neuroimaging has also been used in experimental circumstances to allow